Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 240 years of distinguished history in Japan. We operate from four regions: Japan, U.S., Europe & Canada (EUCAN), and Growth & Emerging Markets (GEM). These four regions are accountable for providing access across our entire portfolio in the countries where we operate.